Consenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico
- Emma L Verástegui
- … show all 1 hide
A topic of great concern in bioethics is the medical research conducted in poor countries sponsored by wealthy nations. Western drug companies increasingly view Latin America as a proper place for clinical research trials. The region combines a large population, modern medical facilities, and low per capita incomes. Participants from developing countries may have little or non alternative means of treatment other than that offered through clinical trials. Therefore, the provision of a valid informed consent is important.
To gain insight about some aspects of the informed consent procedure in a major cancer centre in Mexico, we conducted a three-step evaluation process: 1) a ten point multiple choice survey questionnaires, was used to explore some aspects of the patients' experiences during the informed consent process, 2) researchers' knowledge about specific aspects of the informed consent was evaluated in this study using survey questionnaires; and 3) the comprehensibility, readability and number of pages of the consent forms were analysed. The socioeconomic and educational level of the patients, were also considered. Results were reported using a numerical scale.
Thirty five patients, 20 doctors, and 10 individuals working at the hospital agreed to participate in the study. Eighty three percent of the patients in the study were classified as living in poverty; education level was poor or non existent, and 31% of the patients were illiterate. The consent forms were difficult to understand according to 49% of the patients, most doctors agreed that the forms were not comprehensible to the patients. The average length of the IC documents analysed was 14 pages, and the readability average score was equivalent to 8TH Grade.
The results presented in this work describe some relevant characteristics of the population seen at public health care institutions in Mexico. Poverty, limited or no education, and the complexity of the information provided to the patients may question the validity of the informed consent procedure in this group of patients.
- Porter R: The Greatest Benefits to Mankind. Harper Collins. London, Chapter VII, cited in: British Medical Association. The Medical Profession and Human Rights: Handbook for a Changing Agenda. Research and Experimentation in Humans Zed Books Ltd. New York, NY, US 1997., 206:
- The Nuremberg Code JAMA 1996, 276:1691.JAMA 1996,276:1691.
- World Medical Association: Declaration of Helsinki. JAMA 1997, 277:925–926. CrossRef
- The Belmont Report National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research Washington, DC: US Government Printing Office 1979.
- Council for International Organizations of Medical Sciences: International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: CIOMS 1993.
- Hawkins JS, Emanuel EJ: Clarifying confusions about coercion. Hasting Center Report 2005, 35:16–19.
- Levine RJ: The impact of HIV infection on society's perception of clinical trials. Kennedy Institute J Ethics 1994, 4:93–98.
- Angell M: Ethics of clinical research in third world. N Engl J Med 1997, 337:847–92. CrossRef
- Cleaton-Jones PE: An ethical dilemma: availability of antiretroviral therapy after clinical trials with HIV infected patients re ended. BMJ 1997, 314:887–91.
- Barry M: Ethical considerations of human investigation indeveloping countries: the AIDS dilemma. N Engl J Med 1988, 319:1083. CrossRef
- Angell M: Ethical imperialism-ethics in international collaborative clinical research. N Engl J Med 1988, 319:1081–83. CrossRef
- Annas GJ, Grodin MA: Human rights and maternal-fetal HIV transmission prevention trials in Africa. Am J Public Health 1988, 88:560–3. CrossRef
- Palca J: African AIDS: Whose research rules? Science 1990, 250:199–201. CrossRef
- Emanuel EJ, Wendler D, Grady C: What makes clinical research ethical? JAMA 2000, 283:2701–2711. CrossRef
- Corrigan O: Empty Ethics: The problem with informed consent. Sociology & Health Illness 2003, 25:768–792. CrossRef
- Warren ReichT, editor: Encyclopaedia of Bioethics, [New York: Simon Schuster Macmillan, 1995, 1XXI, cited by Jonsen A.R. Source book. Bioethics. A documentary History (Edited by: Jonsen AR, Veatch RM, Malters LR). Georgetown University Press, Washington DC 1998., 4:
- Jonsen AR: The ethics of research with human subjects: A short history. Source book in Bioethics. A documentary History (Edited by: Jonsen AR, Veatch RM, Malters LR). Georgetown University Press, Washington DC 1998.
- O O'Neill: Some limits of informed consent. J Med Ethics 2003, 29:4–7. doi:10.1136/jme.29.1.4. Downloaded Oct 11,2006 CrossRef
- Dworkin G: The Theory and Practice of Autonomy. New York, NY: Cambridge University Press 1988. CrossRef
- Wolpe P: The Triumph of Autonomy in American Medical Ethics. Bioethics and Society: Sociological Investigations of the Enterprise of Bioethics (Edited by: DeVries R, Subedi H). New York: Prentice-Hall 1998, 38–59.
- Beauchamp TL, Childress J: The Principles of Biomedical Ethics. New York, NY: Oxford University Press 1996.
- Farmer P: Can transnational research be ethical in developing world? Lancet 2000, 360:1266. CrossRef
- Pellegrino E[http://clinicalbioethics.georgetown.edu/faculty/edp.html] 2005.
- Goodyear-Smith F, Lobb B, Davies : International variation in ethics committee requirements: comparisons across five Westernised nations. BMC Med Ethics 2002, 3:2. CrossRef
- Kottow M: The battering of informed consent. J Med Ethics 2004, 30:565–569. CrossRef
- Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R: Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 1995, 13:1062–72.
- Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC: Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001, 358:1772–1777. CrossRef
- Secretaria de Salud: [http://www.salud.gob.mx/]Seguro Popular Fondo de Gastos Catastróficos 2006.
- B Bhutta ZA: Beyond Informed Consent. [http://www.who.int/bulletin/volumes/82/10/]Bulletin of the World Health Organization 2004. Downloaded April 2005
- De Young K, Nelson D: Latin America Is Ripe for Trials, and Fraud. Frantic Pace Could Overwhelm Controls. [http://www.washingtonpost.com]
- Impact of the Pharmaceutical Industry on Medical Research: House of Commons Health Committee August 2004[http://info.cancerresearchuk.org/publicpolicy/consultations/pharmaceuticals/] 2005.
- Verástegui E: Are we working for the pharmaceutical industry? Dissertation Paper. The London School of Economics. MSc BIOS 2005, in press.
- Any circumstances in which individuals are in a position of dependency (research subjects, elderly, indigenous, poor people, dying patients) makes them potentially vulnerable. Research Involving Vulnerable Participants Manual for Research Ethics Committees (Edited by: Eckstein S). Centre of Medical Law and Ethics, Kings College, London. Cambridge University Press 2003, 105.
- Reglamento de la Ley General de Salud en Materia de Investigación para la Salud. Titulo Segundo: De los Aspectos Éticos de la Investigación en Seres Humanos. [http://www.salud.gob.mx/unidades/cdi/nom/compi/rlgsmis.html]Articulo 14 Fracción -V
- International Conference for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH Good Clinical Practices. Manual for Research Ethics Committees (Edited by: Eckstein S). Centre of Medical Law and Ethics, Kings College, London. Cambridge University Press 2003, 133–149.
- Contract regulated by the Mexican civil code Artículo 1794 (Libro Cuarto "De las Obligaciones", el Título Décimo, Capítulo II "De la prestación de servicios profesionales")
- Trejo GG: Código Civil para el Distrito Federal en Materia Común, y para toda la República en Materia Federal. Editorial Sista, S.A. de C.V. México 1995.
- Sepúlveda B: Los derechos del paciente. Gac Méd Méx 1984, 120:271–272.
- Paasche-Orlow MK, Taylor HA, Brancati FL: Readability Standards for Informed-Consent Forms as Compared with Actual Readability. N Eng J Med 2003, 348:721–726. CrossRef
- Kincaid JP, Fishburne RP, Rogers RL, Chissom BS: Derivation of new readability formulas (Automated Readability Index, Fog Count, and Flesch Reading Ease Formula) for Navy enlisted personnel. Research Branch report 8–75. Memphis: Naval Air Station, Doak CC 1975.
- Daugherty CK: Impact of Therapeutic Research on Informed Consent and the Ethics of Clinical Trials: A Medical Oncology Perspective. J Clin Oncol 2003, 17:1601–1617.
- Rueda Mancini, Roberto : Normas Éticas para la Investigación Clínica. [http://www.uchile.cl/bioetica/doc/normas.htm]Disponible en
- La Rocca S, Martinez G, Rascio A, et al.: Biomedical Investigation and Informed Consent in Vulnerable Populations and Individuals. [http://scielo-test.conicyt.cl/scielo.php?script=sci_arttext&pid=S1726–69X2005000200007&lng=en&nrm=iso]Acta Bioeth. [Online] 2005,11(2):169–181. [cited 31 October 2006], ISSN 1726–569X
- Skinner MW, Lillicrap DP, McMillan J: What is cure and how do we get there? Haemophilia 2003, 10:115–188. CrossRef
- Miller F, Brody H: A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hasting Center Report 2003, 33:19–28. CrossRef
- Miller F, Rosenstein D: The therapeutic orientation of clinical trials. New Eng J Med 2003, 348:1383–1386. CrossRef
- Miller F, Silverman H: The ethical relevance of thestandard of care in the design of clinical trials. AM J Respir Crit Care Med 2004, 169:562–564. CrossRef
- Katz J: Experimentation with human beings: the authority of the investigator, subject, professions, and state in the human experimentation process. New York: Russell Sage Foundation 1972, 9–65.
- Preminger BA: The case of Chester M. Southam. Research ethics and the limits of professional responsibility. Pharos Alpha Omega Alpha Honor Med Soc 2002, 65:4–9.
- Drazen JM, Koski G: To protect those who serve. N Engl J Med 2000, 343:1643–1645. CrossRef
- Habiba M, Evans M: The Inter-role Confidentiality Conflict in Recruitment for Clinical Research. The Journal of Medicine and Philosophy 2002, 27:565–587. CrossRef
- Lewens T: Distinguishing treatment from research : a functional approach. J Med Ethics 2006, 32:424–429. CrossRef
- Lindegger G, Richter LM: HIV vaccine trials: Critical issues in informed consent. South African J of Sci 2000, 313:317.
- Emanuel EJ, Wood A, Fleischman A, Bowen A: Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals. Ann Intern Med 2004, 141:282–291.
- Flory J, Emanuel E: Interventions to Improve Research Participants' Understanding in Informed Consent for Research A Systematic Review. [http://www.jama.com]JAMA 2004, 292:1593–1601. INS Nacional, on October 5, 2006 CrossRef
- Meade CD, Howser DM: Consent forms: how to determine and improve their readability. Oncol Nurs Forum 1992, 19:1523–1528.
- Hedegecoe A: Beyond the socialscience critique of applied ethics. Bioethics 2004, 18:1467–8519. (on line)
- Sugarman J, McCrory DC, Powell D: Empirical research on informed consent: an annotated bibliography. Hastings Cent Rep 1999, 29:S1-S42.
- American Society of Clinical Oncology Policy Statement. Oversight of Clinical Research Journal of Clinical Oncology 2003, 21:2377–2386.
- Barbour GL, Blumenkrantz MJ: Videotape aids informed consent decision. JAMA 1978, 240:2741–2742. CrossRef
- Communicating with patients who have limited literacy skills: Report of the National Work Group on Literacy and Health J Fam Pract 1998, 46:168–176.
- Gilman RH, Garcia HH: Ethics review procedures for research in developing countries: a basic presumption of guilt. Can Med Assoc J 2004, 171:248–249. CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6939/7/13/prepub
- Consenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
BMC Medical Ethics
- Online Date
- December 2006
- Online ISSN
- BioMed Central
- Additional Links
- Emma L Verástegui (1) (2)
- Author Affiliations
- 1. Ethics Committee, Instituto Nacional de Cancerologia, Avenida San Fernando 22, Mexico City, Mexico
- 2. Comision Nacional de Bioetica, Torre Zafiro 1, Periferico Sur 4118, piso 1, México City, Mexico